Quanterix Corporation Common Stock QTRX
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-13T18:52:37.667Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-02-19
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T18:50:03.029192147Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T18:50:34.250428+00:00
Quanterix Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 7.25 | 139.1% | 150.1% | |||
| 25Δ | 6.71 | 143.0% | 134.5% | |||
| 30Δ | 6.18 | 147.0% | 118.9% | 2.77 | 88.1% | 22.8% |
| 35Δ | 5.65 | 151.0% | 103.2% | 3.10 | 95.6% | 21.0% |
| 40Δ | 5.11 | 154.9% | 87.6% | 3.43 | 103.2% | 19.2% |
| 45Δ | 4.72 | 145.7% | 75.5% | 3.76 | 110.8% | 17.4% |
| 50Δ | 4.36 | 132.9% | 64.4% | 4.10 | 118.4% | 15.6% |
| 55Δ | 4.00 | 120.2% | 53.3% | 4.43 | 126.0% | 13.9% |
| 60Δ | 3.64 | 107.5% | 42.1% | 4.76 | 133.5% | 12.1% |
| 65Δ | 3.28 | 94.7% | 31.0% | 5.31 | 141.8% | 10.1% |
| 70Δ | 2.92 | 82.0% | 19.9% | 6.42 | 152.0% | 7.9% |
| 75Δ | 2.56 | 69.3% | 8.8% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- 7.25
- IV
- 139.1%
- B/E move
- 150.1%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 6.71
- IV
- 143.0%
- B/E move
- 134.5%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 6.18
- IV
- 147.0%
- B/E move
- 118.9%
- Pseudo strike
- 2.77
- IV
- 88.1%
- B/E move
- 22.8%
35Δ
- Pseudo strike
- 5.65
- IV
- 151.0%
- B/E move
- 103.2%
- Pseudo strike
- 3.10
- IV
- 95.6%
- B/E move
- 21.0%
40Δ
- Pseudo strike
- 5.11
- IV
- 154.9%
- B/E move
- 87.6%
- Pseudo strike
- 3.43
- IV
- 103.2%
- B/E move
- 19.2%
45Δ
- Pseudo strike
- 4.72
- IV
- 145.7%
- B/E move
- 75.5%
- Pseudo strike
- 3.76
- IV
- 110.8%
- B/E move
- 17.4%
50Δ
- Pseudo strike
- 4.36
- IV
- 132.9%
- B/E move
- 64.4%
- Pseudo strike
- 4.10
- IV
- 118.4%
- B/E move
- 15.6%
55Δ
- Pseudo strike
- 4.00
- IV
- 120.2%
- B/E move
- 53.3%
- Pseudo strike
- 4.43
- IV
- 126.0%
- B/E move
- 13.9%
60Δ
- Pseudo strike
- 3.64
- IV
- 107.5%
- B/E move
- 42.1%
- Pseudo strike
- 4.76
- IV
- 133.5%
- B/E move
- 12.1%
65Δ
- Pseudo strike
- 3.28
- IV
- 94.7%
- B/E move
- 31.0%
- Pseudo strike
- 5.31
- IV
- 141.8%
- B/E move
- 10.1%
70Δ
- Pseudo strike
- 2.92
- IV
- 82.0%
- B/E move
- 19.9%
- Pseudo strike
- 6.42
- IV
- 152.0%
- B/E move
- 7.9%
75Δ
- Pseudo strike
- 2.56
- IV
- 69.3%
- B/E move
- 8.8%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Medical Devices
RCEL
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
More →RXST
Rxsight Inc. is a cutting-edge healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions in refractive eye…
More →SENS
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe,…
More →SGHT
Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma…
More →SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The…
More →SNN
Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
More →